Literature DB >> 12785165

Secondary malignant giant cell tumour of bone--a study of five cases with short review of literature.

Asitava Mondal1, Bijon Kundu, Saroj Gupta, Jaydip Biswas.   

Abstract

Secondary malignant giant cell tumour of bone occurs as a result of previous attempts at local control of a benign giant cell tumour of bone (GCT). Out of the total 445 conventional benign GCT of bone, therapeutic irradiation was given in 39 cases as the lesions were located in the vertebrae and pelvic bones where debulking surgery was not possible and the tumours were pressing on the spinal cord. The patients were followed up for 21 years. Out of 39 cases, 5 patients developed sarcomas of which 3 were fibrosarcomas, 1 was malignant fibrous histiocytoma while 1 was an osteosarcoma. All the patients developing post-radiation sarcomas died within a few months due to lung metastasis. In conclusion, all the patients with benign GCT of bone treated with radiation must be followed life long as they are prone to develop sarcomas.

Entities:  

Mesh:

Year:  2002        PMID: 12785165

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  5 in total

Review 1.  Secondary Malignancy in Giant Cell Tumor: A Single-Center Study.

Authors:  Min Wook Joo; Yong-Suk Lee; Hong Sik Park; Yang-Guk Chung; Chiyoung Yoon
Journal:  Curr Oncol       Date:  2022-06-02       Impact factor: 3.109

Review 2.  Malignant giant cell tumour of bone: a review of clinical, pathological and imaging features.

Authors:  Ismail Tahir; Vanghelita Andrei; Robin Pollock; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-09-25       Impact factor: 2.199

3.  Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab.

Authors:  Emanuela Palmerini; Leanne L Seeger; Marco Gambarotti; Alberto Righi; Peter Reichardt; Susan Bukata; Jean-Yves Blay; Tian Dai; Danielle Jandial; Piero Picci
Journal:  BMC Cancer       Date:  2021-01-22       Impact factor: 4.430

4.  Survival and prognosis in malignant giant cell tumor of bone: A population-based analysis from 1984 to 2013.

Authors:  Jia-Liang Lin; Yu-Hao Wu; Yi-Feng Shi; Hao Lin; Majid Nisar; Zaher Meftah; Cong Xu; Jiao-Xiang Chen; Xiang-Yang Wang
Journal:  J Bone Oncol       Date:  2019-09-11       Impact factor: 4.072

5.  The prognosis of giant cell tumor of bone and the vital risk factors that affect its postoperative recurrence: a meta-analysis.

Authors:  Xunge Lin; Jiaqi Liu; Meng Xu
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.